Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
GlyCardial Diagnostics is a spin-off company of the IR-Hospital de la Santa Creu i Sant Pau and the Spanish National Research Council.
EnteraSense is a medical device diagnostic company.
Adaptant is a research-performing software, solutions, and services company dedicated to empowering users over their data.
iOx Therapeutics Ltd. operates as an immuno-oncology company.
experimentQ is a research lab dedicated to lifelong education iD.
Axonista is a video commerce company providing creative, interactive video solutions for various video and TV companies.
Horizon 2020 has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Horizon 2020's top investment sectors include Biotechnology, Health Care, Medical Device, Software, Health Diagnostics. The firm invests across 20 different industry categories.
Among tracked funding rounds, EnteraSense received $2.9M in a Grant round. Horizon 2020's total known invested capital is $268.1M.
Horizon 2020's average investment size is $3.5M across its portfolio of 102 companies.